ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Amydis Announces Successful Completion of Pre-IND Meeting with the FDA
January 15, 2021Amydis announced successful completion of pre-IND (Investigational New Drug) meeting with the U.S. Food and Drug Administration (FDA) regarding the development plan for its lead candidate, AMDX-2011P, a small-molecule retinal tracer that targets ... -
Amydis Receives Grant to Accelerate Development of Alpha-Synuclein Retinal Tracer
August 14, 2020Amydis has received a new grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) for the Company’s pioneering retinal tracer program for alpha-synuclein (ASYN). -
Amydis Awarded NIH Grant for Cerebral Amyloid Angiopathy
September 24, 2019Amydis has received a Phase 2A SBIR grant award from the National Institute on Aging of the National Institutes of Health (NIH).
Pharma Sources Insight January 2025
